Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

103.82
+6.917.13%
Post-market: 103.20-0.6199-0.60%19:58 EDT
Volume:12.94M
Turnover:1.33B
Market Cap:129.14B
PE:21.95
High:104.66
Open:96.79
Low:96.19
Close:96.91
Loading ...

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
9 hours ago

BUZZ-US drugmakers rise as Trump plans broad drug price cuts in executive order

Reuters
·
Yesterday

Stock Track | Gilead Sciences Surges 5% Pre-Market Despite Trump's Drug Price Cut Announcement

Stock Track
·
Yesterday

Pfizer up 2.8%, Eli Lilly up 2.9%, Merck up 4.5%, Gilead Sciences up 4.3%, Abbvie up 1.4%

THOMSON REUTERS
·
Yesterday

Shares of U.S. Pharma Companies Reverse Premarket Course

THOMSON REUTERS
·
Yesterday

Trump Says He Will Cut Drug Prices by 59%

Reuters
·
Yesterday

Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
10 May

BRIEF-Gilead Sciences Inc - Stockholders Reject Dei Practices Risk Report Proposal For Contractors - SEC Filing

Reuters
·
09 May

Gilead Sciences Inc - Stockholders Reject Dei Practices Risk Report Proposal for Contractors - SEC Filing

THOMSON REUTERS
·
09 May

Gilead Sciences Inc. Conducted Annual Stockholder Meeting

Reuters
·
09 May

BUZZ-U.S. STOCKS ON THE MOVE-Tapestry, Carvana, PPG Industries

Reuters
·
08 May

Gilead put volume heavy and directionally bearish

TIPRANKS
·
08 May

BUZZ-U.S. STOCKS ON THE MOVE-Intel, Occidental Petroleum, Kenvue

Reuters
·
08 May

BUZZ-US drugmakers fall on report of Trump plan to lower drug prices

Reuters
·
08 May

COLUMN-The not-so-mysterious case of disappearing boardroom diversity stats: Ross Kerber

Reuters
·
08 May

Gilead boosts planned US investments by $11 billion amid tariff threat

Reuters
·
08 May

Gilead announces $11 billion in new investments in US

Reuters
·
08 May

BRIEF-Gilead To Invest $32 Bln In U.S. Manufacturing And R&D Through 2030

Reuters
·
08 May

Gilead to Invest $32 Billion in U.S. Manufacturing and R&D Through 2030 and Create More Than 3,000 Direct and Indirect Jobs by 2028

THOMSON REUTERS
·
08 May

Gilead Sciences Announces Promising Phase 3 Results: 90% of HDV Patients Maintain Undetectable Virus Levels After Bulevirtide Treatment

Reuters
·
07 May